Laboratorios Farmaceuticos Rovi, S.A. (BME: ROVI)
Spain
· Delayed Price · Currency is EUR 78.30
-0.25 (-0.32%)
Sep 4, 2024, 12:58 PM CET
ROVI Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,094 | 2,106 | 2,449 | 2,234 | 1,526 | 1,407 | Upgrade
|
| Revenue Growth (YoY) | -4.29% | -14.03% | 9.65% | 46.40% | 8.47% | 33.24% | Upgrade
|
| Cost of Revenue | 962.57 | 1,005 | 1,207 | 1,060 | 722.17 | 685.27 | Upgrade
|
| Gross Profit | 1,132 | 1,101 | 1,242 | 1,173 | 803.54 | 721.37 | Upgrade
|
| Selling, General & Admin | 424.11 | 416.85 | 450.83 | 389.95 | 289.6 | 301.43 | Upgrade
|
| Other Operating Expenses | 305.78 | 291.26 | 322.1 | 277.47 | 211.51 | 213.28 | Upgrade
|
| Operating Expenses | 886.96 | 865.38 | 930.04 | 790.01 | 617.43 | 640.67 | Upgrade
|
| Operating Income | 244.63 | 235.69 | 312.46 | 383.41 | 186.1 | 80.69 | Upgrade
|
| Interest Expense | -66.67 | -67.55 | -54.05 | -36.08 | -33.53 | -43.89 | Upgrade
|
| Earnings From Equity Investments | -0.01 | 0.02 | 0.07 | 0.01 | 0.03 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -7.32 | -7.46 | -13.9 | -5.94 | -9.66 | 0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.3 | -2.92 | -11.32 | 0.58 | -3.07 | -7.72 | Upgrade
|
| EBT Excluding Unusual Items | 167.33 | 157.78 | 233.26 | 341.98 | 139.87 | 29.57 | Upgrade
|
| Impairment of Goodwill | - | - | - | -0.09 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.42 | 0.91 | 0.14 | 0.35 | -0.39 | -1.36 | Upgrade
|
| Asset Writedown | -0.54 | -0.54 | -8.28 | -2 | -1.66 | -3.8 | Upgrade
|
| Other Unusual Items | - | - | - | -2.74 | 1.2 | -4.31 | Upgrade
|
| Pretax Income | 167.21 | 158.14 | 225.11 | 337.49 | 139.02 | 20.09 | Upgrade
|
| Income Tax Expense | 41.98 | 41.29 | 60.71 | 81.52 | 39.12 | 5.98 | Upgrade
|
| Earnings From Continuing Operations | 125.23 | 116.85 | 164.4 | 255.97 | 99.9 | 14.11 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.11 | Upgrade
|
| Net Income to Company | 125.23 | 116.85 | 164.4 | 255.97 | 99.9 | 14 | Upgrade
|
| Minority Interest in Earnings | -3.56 | -3.02 | -4.47 | -3.61 | -3.52 | -5.68 | Upgrade
|
| Net Income | 121.67 | 113.83 | 159.93 | 252.36 | 96.39 | 8.32 | Upgrade
|
| Net Income to Common | 121.67 | 113.83 | 159.93 | 252.36 | 96.39 | 8.32 | Upgrade
|
| Net Income Growth | 24.76% | -28.83% | -36.63% | 161.82% | 1058.23% | - | Upgrade
|
| Shares Outstanding (Basic) | 190 | 190 | 189 | 191 | 194 | 194 | Upgrade
|
| Shares Outstanding (Diluted) | 190 | 190 | 189 | 191 | 194 | 194 | Upgrade
|
| Shares Change (YoY) | 0.76% | 0.56% | -1.03% | -1.74% | -0.18% | 27.56% | Upgrade
|
| EPS (Basic) | 0.64 | 0.60 | 0.85 | 1.32 | 0.50 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.64 | 0.60 | 0.85 | 1.32 | 0.50 | 0.04 | Upgrade
|
| EPS Growth | 23.81% | -29.22% | -35.96% | 166.47% | 1060.36% | - | Upgrade
|
| Free Cash Flow | 419.73 | 390.78 | 70.64 | 299.72 | 270.23 | 128.81 | Upgrade
|
| Free Cash Flow Per Share | 2.21 | 2.06 | 0.37 | 1.57 | 1.39 | 0.66 | Upgrade
|
| Dividend Per Share | 0.550 | 0.550 | 0.700 | 0.850 | 0.610 | - | Upgrade
|
| Dividend Growth | -21.43% | -21.43% | -17.65% | 39.34% | - | - | Upgrade
|
| Gross Margin | 54.04% | 52.29% | 50.73% | 52.53% | 52.67% | 51.28% | Upgrade
|
| Operating Margin | 11.68% | 11.19% | 12.76% | 17.16% | 12.20% | 5.74% | Upgrade
|
| Profit Margin | 5.81% | 5.41% | 6.53% | 11.30% | 6.32% | 0.59% | Upgrade
|
| Free Cash Flow Margin | 20.04% | 18.56% | 2.88% | 13.42% | 17.71% | 9.16% | Upgrade
|
| EBITDA | 319.51 | 331.74 | 415.61 | 463.7 | 263.4 | 206.65 | Upgrade
|
| EBITDA Margin | 15.26% | 15.75% | 16.97% | 20.76% | 17.26% | 14.69% | Upgrade
|
| D&A For EBITDA | 74.88 | 96.05 | 103.16 | 80.29 | 77.3 | 125.96 | Upgrade
|
| EBIT | 244.63 | 235.69 | 312.46 | 383.41 | 186.1 | 80.69 | Upgrade
|
| EBIT Margin | 11.68% | 11.19% | 12.76% | 17.16% | 12.20% | 5.74% | Upgrade
|
| Effective Tax Rate | 25.11% | 26.11% | 26.97% | 24.16% | 28.14% | 29.77% | Upgrade
|
| Revenue as Reported | 2,094 | 2,106 | 2,449 | 2,234 | 1,526 | 1,407 | Upgrade
|
| Advertising Expenses | - | 31.15 | 36.3 | 26.21 | 17.16 | 23.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.